-
1
-
-
78149300188
-
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2
-
Mitola S, Ravelli C, Moroni E, et al. Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2. Blood. 2010;116(18):3677-3680.
-
(2010)
Blood
, vol.116
, Issue.18
, pp. 3677-3680
-
-
Mitola, S.1
Ravelli, C.2
Moroni, E.3
-
2
-
-
77954527232
-
Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists
-
Rider CC, Mulloy B. Bone morphogenetic protein and growth differentiation factor cytokine families and their protein antagonists. Biochem J. 2010;429(1):1-12.
-
(2010)
Biochem J
, vol.429
, Issue.1
, pp. 1-12
-
-
Rider, C.C.1
Mulloy, B.2
-
3
-
-
33344474964
-
Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis
-
DOI 10.1016/j.yexcr.2005.11.012, PII S0014482705005215
-
Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res. 2006;312(5):549-560. (Pubitemid 43290332)
-
(2006)
Experimental Cell Research
, vol.312
, Issue.5
, pp. 549-560
-
-
Shibuya, M.1
Claesson-Welsh, L.2
-
4
-
-
0030782410
-
Crystal structure at 1.7 A resolution f VEGF in complex with domain 2 of the Fit-1 receptor
-
Wiesmann C, Fuh G, Christinger HW, Eigenbrot C, Wells JA, de Vos AM. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor. Cell. 1997;91(5):695-704. (Pubitemid 27513660)
-
(1997)
Cell
, vol.91
, Issue.5
, pp. 695-704
-
-
Wiesmann, C.1
Fuh, G.2
Christinger, H.W.3
Eigenbrot, C.4
Wells, J.A.5
De Vos, A.M.6
-
5
-
-
33749528535
-
Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation
-
Sneddon JB, Zhen HH, Montgomery K, et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci US A. 2006;103(40):14842-14847.
-
(2006)
Proc Natl Acad Sci US A
, vol.103
, Issue.40
, pp. 14842-14847
-
-
Sneddon, J.B.1
Zhen, H.H.2
Montgomery, K.3
-
6
-
-
77953590859
-
Bone morphogenetic proteins in breast cancer: Dual role in tumourigenesis?
-
Alarmo EL, Kallioniemi A. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis? Endocr Relat Cancer. 2010;17(2):R123-R139.
-
(2010)
Endocr Relat Cancer
, vol.17
, Issue.2
-
-
Alarmo, E.L.1
Kallioniemi, A.2
-
7
-
-
33847402760
-
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor
-
Stabile H, Mitola S, Moroni E, et al. Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood. 2007;109(5):1834-1840.
-
(2007)
Blood
, vol.109
, Issue.5
, pp. 1834-1840
-
-
Stabile, H.1
Mitola, S.2
Moroni, E.3
-
8
-
-
51649116092
-
Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm
-
Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M. Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm. Blood. 2008;112(4):1154-1157.
-
(2008)
Blood
, vol.112
, Issue.4
, pp. 1154-1157
-
-
Mitola, S.1
Moroni, E.2
Ravelli, C.3
Andres, G.4
Belleri, M.5
Presta, M.6
-
9
-
-
20444364531
-
Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy
-
Dolan V, Murphy M, Sadlier D, et al. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am J Kidney Dis. 2005;45(6):1034-1039.
-
(2005)
Am J Kidney Dis
, vol.45
, Issue.6
, pp. 1034-1039
-
-
Dolan, V.1
Murphy, M.2
Sadlier, D.3
|